VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1649223
Sex: F
Age:
State: CO

Vax Date: 04/10/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Flushed hot cheeks; dizziness; eye discomfort; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 10Apr2021 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. The patient had no medical history. Concomitant medication included bcp (MANUFACTURER UNKNOWN) from unknown date for an unknown indication. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 the patient experienced flushed hot cheeks, dizziness, and eye discomfort. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the reported event. The clinical outcome of the events flushed hot cheeks, dizziness, and eye discomfort were recovered on unknown date in Apr2021. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1649224
Sex: M
Age:
State: IN

Vax Date: 02/20/2021
Onset Date: 02/28/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: left shoulder joint pain; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6201) via an unspecified route of administration in the left arm on 20Feb2021 at 11:45 as a single dose for COVID-19 immunisation. Medical history included stage 1 hypertension and ankle pain from injury. Concomitant medications included telmisartan (MANUFACTURER UNKNOWN) 20 mg, started on an unknown date for unspecified indication and was taking once per day and isradipine (MANUFACTURER UNKNOWN) 2.5 mg, started on an unknown date for unspecified indication and was taking twice per day. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9262) via an unspecified route of administration on 30Jan2021 at 12:15 (at the age of 69-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not tested positive for COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 28Feb2021, the patient experienced right hip and left shoulder joint pain, mild to severe in hip, mild in shoulder and prior ankle pain from long ago injury was now noticeably worse. Therapeutic measures were taken as a result of right hip and left shoulder joint pain, mild to severe in hip, mild in shoulder and ankle pain which included treatment with meloxicam once per day for 14 days. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the events right hip and left shoulder joint pain, mild to severe in hip, mild in shoulder and ankle pain was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: TELMISARTAN; ISRADIPINE

Current Illness:

ID: 1649225
Sex: M
Age:
State: WA

Vax Date: 02/21/2021
Onset Date: 03/18/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Blood tests; Result Unstructured Data: Test Result:UNKNOWN RESULTS; Test Name: Ultrasound; Result Unstructured Data: Test Result:UNKNOWN RESULTS; Test Name: CT scan; Result Unstructured Data: Test Result:UNKNOWN RESULTS

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: Severe lower back pain; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6205) via an unspecified route of administration in the left arm on 21Feb2021 at 11:15 (at the age of 16-years-old) and the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: En6204) via an unspecified route of administration in the left arm on 20Mar2021 (at the age of 16-years-old), both as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to vaccination. Medical history was reported as none. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not take any concomitant medications. The patient did not have any allergies to food, medications, or other products. On 18Mar2021, the patient experienced severe lower back pain. The event resulted in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. Therapeutic measures were taken as a result of severe lower back pain and included treatment with unspecified pain medications. The patient underwent lab tests and procedures which included computed tomography (CT) scan, ultrasound and blood tests on an unknown date and the results were unknown. The clinical outcome of the event severe lower back pain was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1649226
Sex: M
Age:
State: NJ

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Third day - Worse joint pain; ankle pain; knees trouble walking; second day - Joint pain; headache,; tired; First day - Confused feeling; This is a spontaneous report from a contactable consumer, the patient. A 57-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the left arm on 08Apr2021 at 10:00 (at the age of 57-year-old) as a single dose for COVID-19 immunisation. Medical history included hypertension It was unknown whether the patient had allergies to medications, food, or other products. Concomitant medications included losartan (MANUFACTURER UNKNOWN) 25 mg for unknown indication, from unknown time. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021, first day the patient experienced confused feeling. On 09Apr2021, second day the patient experienced joint pain, headache, tired. On 10Apr2021, third day the patient experienced worse joint pain, ankle pain and knees trouble walking. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the adverse events. The clinical outcome of the events confused feeling, joint pain, headache, tired, worse joint pain, ankle pain and knees trouble walking were not recovered, at this time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: LOSARTAN

Current Illness:

ID: 1649227
Sex: F
Age:
State: OH

Vax Date: 04/10/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Strong smelling urine; "administration_date 10Apr2021, dose_number=2/ administration_date 27Mar2021, dose_number=1"; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 12:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no allergies to medications, food, or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 27Mar2021 at 12:00 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not tested for COVID-19. On 10Apr2021, the patient experienced "administration date 10Apr2021, dose number=2/ administration date 27Mar2021, dose number=1". On 11Apr2021 at 08:00, the patient had strong smelling urine. The patient did not receive any treatment for the event. The clinical outcome of the event strong smelling urine was recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1649228
Sex: F
Age:
State: IL

Vax Date: 04/08/2021
Onset Date: 04/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Brain fog; Severe body aches; Painful lymph nodes under left armpit; Low grade fever; Chills; Headaches; Extreme fatigue; Left arm pain at injection site; Swelling of lymph nodes under left armpit; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6207) via an unspecified route of administration in the left arm on 08Apr2021 at 11:30 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Medical history included obesity, high cholesterol and sulphonamide allergy. Concomitant medications included zafirlukast (MANUFACTURER UNKNOWN), ezetimibe (ZETIA), colecalciferol (VITAMIN D3), ascorbic acid; herbal nos; levoglutamide; lysine; magnesium; manganese; retinol; riboflavin; selenium; tocopherol; zinc (AIRBORNE) and ibuprofen (MANUFACTURER UNKNOWN) all for an unknown indication from an unknown date. The patient previously took codeine, quinolones and Zantac and experienced allergy to these medications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 18Mar2021 at 11:30 (at the age of 63-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 at 22:00, the patient experienced low grade fever and chills, severe body aches, headaches, extreme fatigue, left arm pain at injection site, painful swelling of lymph nodes under left armpit and brain fog. The patient did not receive any treatment for the events. The symptoms were the worst between 10 and 48 hours post vaccine but were still present to a lesser extent as of 76 hours post vaccine. The events did not result in doctor or other healthcare professional office or clinic visit, and emergency room or department or urgent care. The clinical outcome of the events low grade fever and chills, severe body aches, headaches, extreme fatigue, left arm pain at injection site, painful swelling of lymph nodes under left armpit and brain fog was recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ZAFIRLUKAST; ZETIA; VITAMIN D3; AIRBORNE; IBUPROFEN

Current Illness:

ID: 1649229
Sex: M
Age:
State: TX

Vax Date: 04/10/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: Hives; Rash; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL 3302) via an unspecified route of administration in the left arm on 10Apr2021 at 10:30 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient was not allergic to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 14:30, the patient experienced hives and rash. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events hives and rash were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1649230
Sex: M
Age:
State: IL

Vax Date: 04/11/2021
Onset Date: 04/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: My throat started to feel swollen; Felt dizzy; Nauseous; Head ache; Weakness; Tired; This is a spontaneous report from a contactable consumer, the patient. A 59-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW 0158) via an unspecified route of administration in the right arm on 11Apr2021 at 12:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient previously received codeine (MANUFACTURER UNKNOWN) and experienced drug allergy. Concomitant medications included ascorbic acid (VITAMIN C) 1000 mg and zinc 50 mg (MANUFACTURER UNKNOWN) on unspecified dates, for unknown indication and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 11Apr2021 at 12:30 approximately 30 minutes after receiving the first dose of vaccine, the patient throat started to feel swollen, felt dizzy, nauseous, head ache, weakness and tired. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. The clinical outcome of the events throat started to feel swollen, felt dizzy, nauseous, head ache, weakness and tired were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN C [ASCORBIC ACID]; ZINC

Current Illness:

ID: 1649231
Sex: F
Age:
State: TX

Vax Date: 04/11/2021
Onset Date: 04/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Felt dizzy and nausea 10 to 15 after receiving shot; Felt dizzy and nausea 10 to 15 after receiving shot; This is a spontaneous report from a contactable pharmacist. An adult non-pregnant female patient of unknown age received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0161) via an intramuscular route of administration in the left arm on 11Apr2021 at 14:30, as a single dose for COVID-19 immunisation. Medical history was not reported. It was unknown whether the patient had any known allergies to food, medications or other products. It was unknown whether the patient received any other medications within two weeks of vaccination. Prior to vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, it was unknown whether the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 11Apr2021, the patient felt dizzy and nausea 10 to 15 after receiving shot. The reporter had to call doctor to pick her up. No therapeutic measures were taken as a result of the events. The clinical outcome of the events felt dizzy and nausea 10 to 15 after receiving shot was resolving at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1649232
Sex: F
Age:
State: FL

Vax Date: 04/07/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: Severe nausea without vomiting; severe diarrhea 2-4 times a day; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: unknown) via an unspecified route of administration in the left arm on 07Apr2021 (at the age of 19-years-old) as a, single dose for COVID-19 immunisation. Medical history was and concomitant medication were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, the patient experienced severe nausea without vomiting and severe diarrhea 2-4 times a day. The events were impacting on the patient's functioning. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of severe nausea without vomiting and severe diarrhea 2-4 times a day were not recovered. No follow-up attempts are needed; information about lot number cannot be obtained.

Other Meds:

Current Illness:

ID: 1649233
Sex: F
Age:
State: MI

Vax Date: 04/10/2021
Onset Date: 04/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Headache; Chills; This is a spontaneous report from a contactable consumer, the patient. A 26-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Apr2021 at 14:30 (at the age of 26-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient did not receive any other medications within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 12:00, the patient experienced headache and chills. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events headache and chills were not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1649234
Sex: F
Age:
State: NC

Vax Date: 04/10/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data: Test Date: 20210411; Test Name: Body temperature; Result Unstructured Data: Test Result:101.2; Comments: Temperature at 12:48 ?101.2; Test Date: 20210411; Test Name: Heart rate; Result Unstructured Data: Test Result:68; Test Date: 20210411; Test Name: Blood pressure; Result Unstructured Data: Test Result:154/80; Test Date: 20210411; Test Name: Body temperature; Result Unstructured Data: Test Result:100.5; Comments: Temperature at 12:25 - 100.5

Allergies:

Symptom List: Rash, Urticaria

Symptoms: blood pressure 154/80; Temperature today at 12:25 pm 100.5Temperature today at 12:48pm 101.2; body aches; extremely thirsty and cant get enough to drink; a little tingling around the lips for just a short time and then it went away; Diarrhea; This is a spontaneous report from a contactable consumer, the patient. A 69-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: ER8727) via an unspecified route of administration in the right arm on 10Apr2021 at 12:00 (at the age of 69-year-old) as a single dose for COVID-19 immunisation. Medical history included breast cancer since 1999, IVP(Intravenous pyelogram) allergy, surgery in 2020, lumpectomy on an unspecified date in Feb2017, lymph node biopsy on 31Mar2021 and COVID-19 from unknown date to an unknown date. Concomitant medications included atenolol (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN) and amlodipine besilate (MANUFACTURER UNKNOWN) for unknown indications from unknown date. The patient previously took tetanus vaccine toxoid (MANUFACTURER UNKNOWN), pentosan polysulfate sodium (ELMIRON), atorvastatin calcium (LIPITOR), rosuvastatin calcium (CRESTOR), methotrexate(MANUFACTURER UNKNOWN), boric acid (MANUFACTURER UNKNOWN), sulfamethoxazole, trimethoprim(SEPTRA) and experienced allergy. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 12:45, the patient experienced a little tingling around the lips for just a short time and then it went away and at night had diarrhea and also on 11Apr2021 (next day) morning. On 11Apr2021, the patient was extreme thirsty and cannot get enough to drink, body aches and at 12:25, the patient had temperature of 100.5(fever), at 12:47, the patient had a blood pressure of 154/80(high blood pressure) and at 12:48, temperature of 101.2. The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other health care professional office/clinic visit and emergency room/department or urgent care. On 11Apr2021, the patient underwent body temperature, blood pressure, heart rate tests and resulted with a temperature of 100.5 and 101.2(unspecified units), blood pressure of 154/80(unspecified units) and heart rate of 68(unspecified units). The clinical outcome of the event tingling lips was recovered on 10Apr2021, while that of diarrhea, body aches, extreme thirsty, temperature of 100.5, 101.2 and blood pressure of 154/80 were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ATENOLOL; HYDROCHLOROTHIAZIDE; AMLODIPINE BESYLATE

Current Illness:

ID: 1649235
Sex: F
Age:
State: OR

Vax Date: 03/17/2021
Onset Date: 04/03/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Shingles; This is a spontaneous report from a contactable consumer, the patient. A 66-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 17Mar2021 at 08:30, as a single dose for COVID-19 immunisation. Medical history included mild hypertension. The patient did not have any known allergies. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN) and alprazolam (MANUFACTURER UNKNOWN), both started on an unknown date for unspecified indication. The patient previously took two doses of shingles vaccinations in 2018. Prior to the vaccination, the patient was not tested positive for COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 03Apr2021, 1.5 weeks after vaccination, the patient experienced shingles. Therapeutic measures were taken as a result of shingles which included treatment with antiviral medication. The events resulted in doctor or other healthcare professional office/clinic visit. The clinical outcome of the event shingles was recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: LISINOPRIL; ALPRAZOLAM

Current Illness:

ID: 1649236
Sex: F
Age:
State: CA

Vax Date: 03/31/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: tiredness; chilly; nausea; feeling unwell; dizziness; "weakness worst"; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8733) via an unspecified route of administration in the left arm on 31Mar2021 at 10:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included vertigo. The patient had no known allergies. The patient received unspecified medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 09:00, the patient experienced tiredness, chilly, nausea, feeling unwell, dizziness and weakness (worst). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of tiredness, chilly, nausea, feeling unwell, dizziness and weakness (worst) which included treatment with MECLIZINE. The clinical outcome of the events tiredness, chilly, nausea, feeling unwell, dizziness and "weakness worst" were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1649237
Sex: M
Age:
State: NY

Vax Date: 04/10/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210407; Test Name: Rapid antigen; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Hypersensitive nerves (putting on clothes, or rubbing of skin is painful); Fever; Chills; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 10Apr2021 at 10:30 (at the age of 22-years-old) as a single dose for COVID-19 immunization. Medical history was not reported. Concomitant medications included escitalopram oxalate (LEXAPRO) 15 mg and bupropion (MANUFACTURER UNKNOWN) 150 mg; both for an unknown indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the left arm on 27Mar2021 at 10:30 (at the age of 22-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 10Apr2021 at 22:00, the patient experienced hypersensitive nerves (putting on clothes, or rubbing of skin is painful), fever and chills. On 07Apr2021 (post vaccination), the patient underwent PCR (nasal swab/rapid antigen) and the result was negative. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events, hypersensitive nerves (putting on clothes, or rubbing of skin is painful), fever and chills was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LEXAPRO; BUPROPION

Current Illness:

ID: 1649238
Sex: F
Age:
State: NY

Vax Date: 04/11/2021
Onset Date: 04/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Left side of face feels slightly numb/numbness started in jaw and felt like it moved up into cheeks and towards head; Headache; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 2613) via an unspecified route of administration in the left arm on 11Apr2021 at 12:45 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. The patient had no past medical history. The patient had no known allergies to medications, food, or other products. Concomitant medication included birth control (MANUFACTURER UNKNOWN); taken on an unknown date for unknown indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 13:45, the patient experienced left side of face feels slightly numb. The numbness started in jaw and felt like it moved up into cheeks and towards head. This feeling was getting less intense as times went on, but still felt it five hours she received the vaccine. The patient also had a headache. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events left side of face feels slightly numb/ numbness started in jaw and felt like it moved up into cheeks and towards head and headache were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1649239
Sex: F
Age:
State: MA

Vax Date:
Onset Date: 04/02/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies: Allergy to nuts

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: This is a spontaneous report from a noncontactable consumer (patient). A 33-year-old (non-pregnant) female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, batch/lot# unknown), at the age of 33, via an unspecified route of administration, right arm, on an unknown date, single dose, for COVID-19 immunisation. Medical history and concomitant medication not reported. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine, batch/lot# unknown), via an unspecified route of administration, on an unknown date, single dose, for COVID-19 immunisation. The patient is allergic to nuts. Prior to vaccination, it was unknown whether patient was diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On Apr 2, 2021, patient felt like she had flu and had swollen arm pits (lymphadenopathy). The patient did not receive any treatment for the reported events. The adverse events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of felt like flu and swollen arm pits recovered on an unknown date in Apr 2021. No follow-up attempts possible. Information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1649240
Sex: F
Age:
State: NC

Vax Date: 03/26/2021
Onset Date: 03/29/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Mucous; Headache; shingles on head and forehead; This is a spontaneous report from a contactable consumer, the patient. A 53-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727), via an unspecified route of administration in the left arm on 26Mar2021 at 11:30 (at the age of 53-years-old), as a single dose for COVID-19 immunisation. Medical history included cyclical neutropenia immune deficiency. The patient did not have any allergies to medications, food or other products. Concomitant medications were not provided. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 29Mar2021 at 12:00, the patient experienced mucous, headache and then shingles on head and forehead. Shingles diagnosed by urgent care. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles which included treatment with antiviral medicine. The clinical outcome of the events mucous, headache and then shingles on head and forehead were not resolved at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1649241
Sex: F
Age:
State: CA

Vax Date: 04/02/2021
Onset Date: 04/02/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Nauseated time onset still going; Sore arm; Loss of appetite; Dry skin patch; Weight loss of 2 lbs; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: unknown) via an unspecified route of administration in the left arm on 02Apr2021 at 12:00 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient had known allergies to collins and also had seasonal allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 02Apr2021 at 14:15 the patient experienced nauseated time onset was still going two days later, sore arm, loss of appetite, dry skin patch and weight loss of 2 lbs. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of reported events. The clinical outcome of the events nauseated time onset was still going two days later, sore arm, loss of appetite, dry skin patch and weight loss were all not recovered at the time of this report. No follow-up attempts are needed; information about lot\batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1649242
Sex: F
Age:
State: CO

Vax Date: 04/09/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: painful swelling of the lymph node in my right armpit after my second dose (which was in my right arm); painful swelling of the lymph node in my right armpit after my second dose (which was in my right arm); This is a spontaneous report from a contactable consumer, the patient. A 40-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER87729) via an unspecified route of administration in the right arm on 09Apr2021 at 13:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Medical history included depression (reported as depressing), generalized anxiety disorder (GAD), post-traumatic stress disorder (PTSD), attention deficit disorder (ADD) and scoliosis. The patient had sensitivity to nickel (nickel allergy) and pollen allergy (pine pollen and cottonwood pollen). The patient had received other medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6955) via an unspecified route of administration in the left arm on 19Mar2021 at 13:30 (at the age of 40-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 06:00, the patient experienced painful swelling of the lymph node in her right armpit after her second dose (which was in her right arm). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events painful swelling of the lymph node in right armpit after second dose (which was in right arm) was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1649243
Sex: M
Age:
State: TX

Vax Date: 03/12/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Pain level 9 in right shoulder; radiating to the neck; This is a spontaneous report from a contactable consumer, the patient. A 67-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: FN6197) via an unspecified route of administration in the left arm on 12Mar2021 at 09:30 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. Medical history included stomach cancer and bladder cancer. The patient had no allergies to medications, food, or other products. Concomitant medications included imatinib mesilate (GLEEVEC) for cancer treatment from an unknown date. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EM9809) via an unspecified route of administration in the arm left on 19Feb2021 at 13:15 (at the age of 67-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, the patient experienced pain level 9 in the right shoulder and was radiating to the neck. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event pain level 9 in the right shoulder and radiating to the neck was not recovered at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds: GLEEVEC

Current Illness:

ID: 1649244
Sex: F
Age:
State: FL

Vax Date: 02/24/2021
Onset Date: 02/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: COVID test; Result Unstructured Data: Test Result:Unknown; Comments: Nasal Swab

Allergies:

Symptom List: Unevaluable event

Symptoms: Lack of sleep; This is a spontaneous report from a contactable consumer, the patient. A 61-year-old non-pregnant female patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6198) via an unspecified route of administration in the left arm on 24Feb2021 at 14:45 (at the age of 61-years-old) as a single dose for COVID-19 immunisation. Medical history not reported. Concomitant medication included chemotherapy from an unknown date, for unknown indication and unknown if ongoing. The patient had no known allergies to food, medications or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 24Feb2021 at 23:00, the patient experienced lack of sleep. On an unknown date, the patient underwent SARS Cov2 test (nasal swab test) and the result was unknown. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of reported event. The clinical outcome of the event lack of sleep was recovered on an unknown date in 2021 at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1649245
Sex: F
Age:
State: MI

Vax Date: 04/05/2021
Onset Date: 04/06/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: Started to have hives; This is a spontaneous report from a contactable consumer, the patient. A 52-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534, expiration date: 31Jul2021) via an unspecified route of administration in the right arm on 05Apr2021 at 12:15 (at the age of 52-years-old) as a single dose for COVID-19 immunisation. The patient reported that she had no known chronic conditions. It was unknown if the patient had any allergies to medications, food, or other products. The patient did not receive any medication within two weeks of the COVID-19 vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 06Apr2021 at 19:00, the patient started to have hives. The patient reported that she has had hives every night since. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the event and included treatment with 5 mg of cetirizine HCl (cetirizine hydrochloride). The clinical outcome of the event hives was unknown at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1649246
Sex: F
Age:
State: MD

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: constant headache since 3/31, jaw pain/teeth and gums, back of nose and upper throat feels like it is on fire/burned, intermittent ear ache. Intermittent chest palpitations; constant headache since 3/31, jaw pain/teeth and gums, back of nose and upper throat feels like it is on fire/burned, intermittent ear ache. Intermittent chest palpitations; constant headache since 3/31, jaw pain/teeth and gums, back of nose and upper throat feels like it is on fire/burned, intermittent ear ache. Intermittent chest palpitations; constant headache since 3/31, jaw pain/teeth and gums, back of nose and upper throat feels like it is on fire/burned, intermittent ear ache. Intermittent chest palpitations; constant headache since 3/31, jaw pain/teeth and gums, back of nose and upper throat feels like it is on fire/burned, intermittent ear ache. Intermittent chest palpitations; constant headache since 3/31, jaw pain/teeth and gums, back of nose and upper throat feels like it is on fire/burned, intermittent ear ache. Intermittent chest palpitations; constant headache since 3/31, jaw pain/teeth and gums, back of nose and upper throat feels like it is on fire/burned, intermittent ear ache. Intermittent chest palpitations; constant headache since 3/31, jaw pain/teeth and gums, back of nose and upper throat feels like it is on fire/burned, intermittent ear ache. Intermittent chest palpitations; This is a spontaneous report from a contactable nurse, the patient. A 51-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 31Mar2021 at 11:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. The patient previously took Codeine and experienced drug allergy. Concomitant medications taken within two weeks prior to vaccination included esomeprazole magnesium (NEXIUM) from unknown date for unknown indication. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 10Mar2021 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient experienced constant headache since 31Mar2021 and on 02Apr2021 jaw pain/teeth and gums, back of nose and upper throat felt like it was on fire/burned, intermittent ear ache. The patient also experienced intermittent chest palpitations on 02Apr2021. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events constant headache since 31Mar2021, jaw pain/teeth and gums, back of nose and upper throat felt like it was on fire/burned, intermittent ear ache, intermittent chest palpitations was not resolved at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: NEXIUM [ESOMEPRAZOLE MAGNESIUM]

Current Illness:

ID: 1649247
Sex: M
Age:
State: CA

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 20210409; Test Name: Body temperature; Result Unstructured Data: Test Result:100.5; Comments: 100.5 fever started 12 hours after shot

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Chills; 100.5 fever started 12 hours after shot; Sore arm; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8729) via an unspecified route of administration in the left arm on 09Apr2021 at 11:30(at the age of 56-year-old) as a single dose for COVID-19 immunisation. Medical history included ulcerative colitis and type 2 diabetes mellitus from an unknown date. Concomitant medications included azathioprine (IMURAN), mesalazine (MESALAMINE), atorvastatin calcium (LIPITOR) and glucosamine (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient had no known allergies to medications, food or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 19Mar2021 at 11:30(at the age of 56-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 23:30 the patient experienced chills and 100.5 fever started 12 hours after shot. Sore arm, fever went down after 36 hours, but got back up in the afternoon, about 42 hours after shot. The events did not result in doctor or other healthcare professional office/clinic, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events chills, 100.5 fever and sore arm was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: IMURAN [AZATHIOPRINE]; MESALAMINE; LIPITOR; GLUCOSAMINE

Current Illness:

ID: 1649248
Sex: F
Age:
State: MD

Vax Date: 02/09/2021
Onset Date: 03/28/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Shingles; burning right hip; tingling pain in the right hip; This is a spontaneous report from a contactable physician. A 53-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: el9264) via an unspecified route of administration in the left arm on 09Feb2021 at 11:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. The patient's medical history included sulfonamide allergy. Concomitant medications included vitamin D3 2000iu (MANUFACTURER UNKNOWN) and b complex (MANUFACTURER UNKNOWN), both since unknown dates and for unknown indications. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: el1283) via an unspecified route of administration in the left arm on 12Jan2021 at 12:00 (at the age of 53-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. On 28Mar2021 at 14:00, the patient experienced burning tingling pain in the right hip. On 04Apr2021, the patient experienced shingles. The adverse events did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcomes of the events burning right hip, tingling pain in the right hip and shingles were recovering at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1649249
Sex: F
Age:
State: MA

Vax Date: 03/25/2021
Onset Date: 03/26/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Mar2021 at 12:00 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included none. Patient had unspecified known allergies. Concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 25Feb2021 at 14:15 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 26Mar2021 the patient experienced consistent headaches and tiredness. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of events consistent headaches and tiredness was unknown. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1649250
Sex: M
Age:
State: WA

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210410; Test Name: Blood glucose level; Result Unstructured Data: Test Result:400 and more; Test Date: 20210411; Test Name: Blood glucose level; Result Unstructured Data: Test Result:Normal; Comments: at 2-4 AM.

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: The patient's blood glucose was 400 and more (no unit provided) on 10Apr2021; Blood glucose levels started rising; glucose level had reached 400 and more; Blood glucose levels started rising; glucose level had reached 400 and more; Soreness at the injection site; This is a spontaneous report from a contactable nurse (patient's grandmother). A 16-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205) via an unspecified route of administration, administered in left arm on 09Apr2021 10:45 (at the age of 16-year-old) as a single dose for COVID-19 immunization. Medical history included type 1 diabetes mellitus and hypothyroidism. Concomitant medications included levothyroxine (manufacturer unknown) and insulin lispro (HUMALOG) via insulin pump; both taken for an unspecified indication, start and stop date were not reported. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021, the patient experienced soreness at the injection site and blood glucose levels started rising. The patient's blood glucose was 400 and more (no unit provided) on 10Apr2021 and blood glucose was normal on 11Apr2021 at 2-4 AM. The clinical course was reported as follows: "I am retired RN and grandmother reporting for my grandson who has type 1 diabetes and uses insulin pump. Initially he experienced no adverse events after injection of vaccine. Approximately 6-7 hours after receiving the vaccine (09Apr2021), his blood glucose levels started rising. He had dosed insulin correctly upon eating. Throughout the evening his blood glucose continued to rise and did not respond to usual doses on insulin. We changed the insertion site for the pump 2x, changed pump cassette and added insulin to the cassette from a new insulin cartridge. On Saturday 10Apr2021, glucose level had reached 400 and more. Glucose level returned to his normal on 11Apr2021 @ 2-4 AM. He had no other adverse symptoms other than a bit of soreness at the injection site. We did not see anything specific in vaccine info about diabetics getting elevated blood glucose. I would like to suggest this be added to patient educational materials." No treatment was received for the adverse events (as reported). The clinical outcome of the event "blood glucose levels started rising; glucose level had reached 400 and more" was resolved on 11Apr2021 and the event "soreness at the injection site" was resolved on an unspecified date in Apr2021.; Sender's Comments: Based on the known safety profile of the vaccine BNT162B2, a temporal relation between the events: Diabetes Mellitus, Condition Aggravated, Blood Glucose Increased and the administration of the vaccine cannot be excluded.The impact of this report on the benefit/risk profile of the Pfizer product is evaluated as part of Pfizer procedures for safety evaluation, including the review and analysis of aggregate data for adverse events. Any safety concern identified as part of this review, as well as any appropriate action in response, will be promptly notified to regulatory authorities, Ethics Committees, and Investigators, as appropriate.

Other Meds: LEVOTHYROXINE; HUMALOG

Current Illness:

ID: 1649251
Sex: F
Age:
State: KY

Vax Date: 03/31/2021
Onset Date: 04/02/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: This is a spontaneous report from a contactable consumer (patient). A 75-year-old female patient received the second dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# ER8730), at the age of 75, via an unspecified route of administration, right arm, on Mar 31, 2021, at 11:00, single dose, for COVID-19 immunisation. Medical history included high blood pressure, arthritis and COVID-19. The patient did not have a history of allergies to any food or medications or other products. Concomitant medications included Celebrex (celecoxib), Novasen (acetylsalicylic acid) and daily vitamins for an unknown indication, on an unknown date. The patient previously received the first dose of BNT162B2 (Pfizer-BioNTech COVID-19 mRNA vaccine; batch/lot# unknown), at the age of 75, via an unspecified route of administration, left arm, on Mar 10, 2021, at 11:00, single dose, for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, patient was diagnosed with COVID-19. Since the vaccination, patient has not tested for COVID-19. On Apr 2, 2021, patient experienced more tired than usual, seemed to be in fog at times and really sore at injection site at times (like someone was hitting the patient). The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures taken for the events. The clinical outcome of more tired than usual, seemed to be in fog at times and really sore at injection site recovered with sequelae on an unknown date in Apr 2021. No follow-up attempts are needed. Information about lot/batch number cannot be obtained. No further information expected.

Other Meds: Celebrex; Novasen; daily vitamins

Current Illness:

ID: 1649252
Sex: F
Age:
State: MA

Vax Date: 04/11/2021
Onset Date: 04/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: The right side of face (ear, cheek, jaw, gland, tongue slightly), got tingly; The right side of my face (ear, cheek, jaw, gland, tongue slightly), got tingly/number a hour after my second shot. I took two bendryl in case. Past4 hour mark still slightly numb but slightly better.; The right side of my face (ear, cheek, jaw, gland, tongue slightly), got tingly; This is a spontaneous report from a contactable consumer, the patient. A 41-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0153), via an unspecified route of administration in the left arm on 11Apr2021 at 15:15 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had reported seasonal allergies to (pollen and mold spores). Concomitant medications included loratadine (CLARITIN) from unknown date for unspecified indication. The patient previously received the first dose of BNT162b2 (PFIZER BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP6956), via an unspecified route of administration in the left arm on 21Mar2021 at 16:00 (at the age of 41-years-old), as a single dose for COVID-19 immunisation. The patient previously received pertussis vaccine (MANUFACTURER UNKNOWN) on unknown date for an unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 16:15, the patient experienced the right side of face (ear, cheek, jaw, gland, tongue slightly), got tingly/numb a hour after the second shot. The patient took two bendryl and after 4 hours still patient felt slightly numb but slightly better and there was no facial drooping. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with bendryl. The clinical outcome of the events the right side of face (ear, cheek, jaw, gland, tongue slightly), got tingly/numb a hour after the second shot, past 4 hour mark still slightly numb but slightly better were resolving at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds: CLARITIN [LORATADINE]

Current Illness:

ID: 1649253
Sex: F
Age:
State: CA

Vax Date: 04/10/2021
Onset Date: 04/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Severe bloody noses around 28 hours after first dose; This is a spontaneous report from a contactable consumer, the patient. A 23-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE;Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 10Apr2021 at 12:45 (at the age of 23-years-old) as a single dose for COVID-19 immunisation. Medical history included attention deficit hyperactivity disorder (ADHD), bipolar II disorder, depression, polycystic ovarian syndrome(PCOS), gastroesophageal reflux disease (GERD).The patient had known allergy to insect bite (bee venom). The patient had other medications received in two weeks which had not enough room to list. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 15:45 ,the patient experienced severe bloody noses around 28 hours after first dose. The patient did not have any history of prior bloody noses. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the event. The clinical outcome of the event severe bloody noses around 28 hours after first dose was resolving at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1649254
Sex: F
Age:
State: NC

Vax Date: 04/09/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210410; Test Name: Body temperature; Result Unstructured Data: Test Result:101; Comments: Fever of 101

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Red hot itchy raised circle above vaccination area; Red hot itchy raised circle above vaccination area; quarter sized.; Headache; Fever of 101; Nausea; Chills; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the arm right on 09Apr2021 at 12:00(at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included sulfonamide allergy and penicillin allergy. Concomitant medications included Botox, ibuprofen (MANUFACTURER UNKNOWN) and loratadine (CLARITIN) for unknown indication and from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date in 2021(at the age of 50 years old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021, the patient experienced a red hot itchy raised circle above the vaccination area; quarter-sized. The patient did experience side effects like headache, fever of 101, nausea, and chills. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events red hot itchy raised circle above the vaccination area, headache, fever of 101, nausea, and chills were recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: BOTOX; IBUPROFEN; CLARITIN [LORATADINE]

Current Illness:

ID: 1649255
Sex: F
Age:
State: DE

Vax Date: 04/06/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Recurrent gentian herpes outbreak;This is a spontaneous report from a contactable consumer, the patient. A 25-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 06Apr2021 at 11:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included ethinylestradiol, norgestimate (TRINESSA LO) from an unknown date for birth control, spironolactone (MANUFACTURER UNKNOWN) from an unknown date for an unspecified indication. It was unknown if the patient was pregnant. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 15:00, the patient experienced recurrent gentian herpes outbreak. The event resulted in doctor or other healthcare professional office/clinic visit. The patient did not receive any treatment for the event. The clinical outcome of the event Recurrent gentian herpes outbreak was resolving. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: TRINESSA LO; SPIRONOLACTONE

Current Illness:

ID: 1649256
Sex: F
Age:
State: NC

Vax Date: 04/07/2021
Onset Date: 04/07/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Burning in breasts; Shooting pain in nipples; Keeping me up at night.; This is a spontaneous report from a contactable consumer, the patient. An unspecified aged non-pregnant female patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7533) via an unspecified route of administration in the right arm on 07Apr2021 at 13:15 as a single dose for COVID-19 immunisation. Medical history included hypertension and chronic migraines. The patient had no known allergies to medications, food or other products. The patient received unspecified medication within two weeks of vaccination. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EP7534) via an unspecified route of administration in the left arm on 17Mar2021 at 13:45 as a single dose for COVID-19 immunisation. The patient did not receive any other vaccine within four weeks prior to the COVID vaccine. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 07Apr2021 at 15:30, the patient experienced burning in breasts and shooting pain in nipples which was keeping the patient up at night. After the first day only in the right breast and had continued through day 4. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. It was unknown whether any therapeutic measures were taken as a result of reported events. The clinical outcomes of burning in breasts and shooting pain in nipples were recovering at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1649257
Sex: M
Age:
State: FL

Vax Date: 03/20/2021
Onset Date: 03/28/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Rash; Hives; This is a spontaneous report from a contactable consumer, patient. A 61-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2618) via an unspecified route of administration in the left arm on 20Mar2021 at 13:30 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. Medical history included coronary artery disease and blood pressure high. The patient had no known allergies to medications, food, or other products. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 28Mar2021, the patient experienced rash and hives. The adverse events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events of rash and hives were not recovered at the time of report. Patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number:EP7533) via an unspecified route of administration in the left arm on 10Apr2021 (at the age of 61-year-old) as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1649258
Sex: F
Age:
State: FL

Vax Date: 03/17/2021
Onset Date: 03/26/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Joint pain in both arms; itching both arms intermittent till now; pain in hips; pain in knees; swelling in legs; swelling in right knee; This is a spontaneous report from a contactable consumer, the patient. A 78-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Enu20u) via an unspecified route of administration in the left arm on 17Mar2021 at 09:15 (at the age of 78-years-old) as a single dose for COVID-19 immunisation. Medical history included acid reflux (esophageal), cholesterol and blood pressure. The patient had known allergy to iodine, antibiotic, prednisone and sulphur. Concomitant medications included losartan (MANUFACTURER UNKNOWN), omeprazole (MANUFACTURER UNKNOWN), prednisone (MANUFACTURER UNKNOWN), simvastatin (MANUFACTURER UNKNOWN) and acetylsalicylic acid (ASPIRIN); all from unknown dates and for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not received any other vaccines within four weeks prior to the COVID vaccine. On 26Mar2021, the patient experienced joint pain in both arms, itching both arms intermittent till now, pain in hips, pain in knees, swelling in legs, more prominent swelling in right knee. The events resulted in doctor or other healthcare professional office/clinic visit. No therapeutic measures were taken as a result of the events. The clinical outcome of the event of joint pain in both arms, itching, pain in hip, pain in knees, swelling of legs and swelling in right knee was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LOSARTAN; OMEPRAZOLE; SIMVASTATIN; ASPIRIN [ACETYLSALICYLIC ACID]; PREDNISONE

Current Illness: Acid reflux (esophageal) (Being treated for acid reflux)

ID: 1649259
Sex: M
Age:
State: FL

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Blurred short (reading) distance; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 09Apr2021 at 13:15 (at the age of 39-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient had no known drug allergies. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09Apr2021 at 15:00, the patient experienced blurred short (reading) distance. Over the course of 2-3 days, clear sight has returned. The adverse event did not result in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. It was unknown whether the patient received any treatment for the event. The clinical outcome of the event blurred short (reading) distance was resolving at the time of reporting. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1649260
Sex: F
Age:
State: NY

Vax Date: 04/09/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: Intense arm pain; Mouth ulcer; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EIN 0151) via an unspecified route of administration in the left arm on 09Apr2021 at 11:00 (at the age of 38-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient had no food and drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 10Apr2021 at 03:00, the patient experienced intense arm pain and mouth ulcer. It was unknown whether any therapeutic measures were taken as a result of the events. The clinical outcome of the events intense arm pain and mouth ulcer was not resolved at the time of the report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1649261
Sex: M
Age:
State: NC

Vax Date: 04/10/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Dizziness; Fatigue; Metallic taste in mouth; Soreness; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0151) via an unspecified route of administration in the left arm on 10Apr2021 at 08:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included none. Concomitant medications included linum usitatissimum seed oil (FLAXSEED OIL); on an unknown date for unknown indication. The patient previously took Zithromax and experienced drug allergy. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER2613) via an unspecified route of administration in the left arm on 20Mar2021 at 08:15 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 08:30, the patient experienced dizziness, fatigue, soreness and metallic taste in mouth. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events dizziness, fatigue, soreness and metallic taste in mouth were resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: FLAXSEED OIL [LINUM USITATISSIMUM SEED OIL]

Current Illness:

ID: 1649262
Sex: M
Age:
State: OH

Vax Date: 03/31/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210410; Test Name: Body temperature; Result Unstructured Data: Test Result:101 Units:[degF]; Comments: fever 101 f

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: The swollen part red; Swollen part little painful; Swollen lymph node having almost size of peas below the right chin; Fever 101 f; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: Er2613) via an unspecified route of administration in the left arm on 31Mar2021 at 17:30 (at the age of 37-year-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 10Apr2021 at 06:00, the patient experienced swollen lymph node having almost the size of peas below the right chin. The swollen part was red and it was a little painful when it was touched. On the same day, during the evening, the patient got a fever of 101 Fahrenheit (f). The patient did not get any other side effects of fever even after 10 days of taking the vaccine. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department, or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event swollen lymph node having almost size of peas below the right chin, fever 101 f, the swollen part red, and swollen part little painful were not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1649263
Sex: F
Age:
State:

Vax Date: 04/09/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: Frequent muscle twitching at the location of the vaccine in the left arm.; This is a spontaneous report from a non-contactable consumer, the patient. A 57-year-old female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 09Apr2021 at 11:45 (at the age of 57-years-old) as a single dose for COVID-19 immunisation. Medical history included diabetes type 2. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), metformin hydrochloride; sitagliptin phosphate monohydrate (JANUMET), metformin (MANUFACTURER UNKNOWN), magnesium (MANUFACTURER UNKNOWN and vitamin d nos (VITAMIN D); all for unknown indications from unknown dates. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 10Apr2021 at 07:00, the patient experienced frequent muscle twitching at the location of the vaccine in the left arm. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the event. The clinical outcome of the event frequent muscle twitching at the location of the vaccine in the left arm was not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: LISINOPRIL; JANUMET; METFORMIN; MAGNESIUM; VITAMIN D [VITAMIN D NOS]

Current Illness:

ID: 1649264
Sex: M
Age:
State: VA

Vax Date: 03/31/2021
Onset Date: 03/31/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: Partial numbness/tingling sensation in left arm; Partial numbness left half of face; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the left arm on 31Mar2021 at 18:45 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included blood pressure high, narcolepsy, and sleep apnea. The patient did not have a history of allergies to medications, food, or other products. Concomitant medications included amlodipine besilate (AMLODIPINE BESYLATE), amfetamine aspartate, amfetamine sulfate, dexamfetamine saccharate, dexamfetamine sulfate (ADDERALL); both from unknown dates and for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 31Mar2021 at 19:00 the patient experienced partial numbness/tingling sensation in left arm and left half of face beginning within 20 minutes of injection, and subsiding after about 2 hours. The patient seemed to retain full muscle control throughout this time. Therapeutic measures were not taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. The clinical outcome of the events partial numbness/tingling sensation in left arm and partial numbness left half of face were recovered on 31Mar2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ADDERALL; AMLODIPINE BESYLATE

Current Illness:

ID: 1649265
Sex: F
Age:
State: CO

Vax Date: 04/02/2021
Onset Date: 04/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Slightly sore, itchy splotches; Rash at injection site halfway down toelbow. Pink, slightly sore, itchysplotches.; Rash at injection site halfway down to elbow; Pink, slightly sore, itchy splotches.; itchy splotches.; This is a spontaneous report from a contactable consumer, the patient. A 33-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 02Apr2021 at 11:30 (at the age of 33-years-old) as a single dose for COVID-19 immunisation. Medical history, concomitant medications were not reported. It was unknown if the patient had allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 08:00, the patient experienced rash at injection site halfway down to elbow. Pink, slightly sore, itchy splotches. The patient did not receive any treatment for the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events rash at injection site halfway down to elbow. Pink, slightly sore, itchy splotches was not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1649266
Sex: F
Age:
State: NJ

Vax Date: 03/31/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: 36 hours after injection, experienced severe, debilitating vertigo that last 3 days.; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8727) via an unspecified route of administration in the right arm on 31Mar2021 at 08:30 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included montelukast sodium (SINGULAIR) and salbutamol (ALBUTEROL) from an unknown date for unspecified indications. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6205,) via an unspecified route of administration in the right arm on 10 Mar2021 at 08:30 (at the age of 50-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01Apr2021 at 20:30, 36 hours after injection, the patient experienced severe, debilitating vertigo that lasted 3 days. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the severe debilitating vertigo. The clinical outcome of the event severe, debilitating vertigo was recovered on 04Apr2021. No follow-up attempts are needed. No further information is expected.

Other Meds: SINGULAIR; ALBUTEROL [SALBUTAMOL]

Current Illness:

ID: 1649267
Sex: F
Age:
State: CA

Vax Date: 03/30/2021
Onset Date: 04/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: persistent blurred vision; Weakness in the chest area; This is a spontaneous report from a contactable consumer, the patient. A 56-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 30Mar2021 at 16:00 (at the age of 56-years-old) as a single dose for COVID-19 immunisation. Medical history included depression. The patient did not have any allergies to medication, food or any other products. Concomitant medications included bupropion hydrochloride (WELLBUTRINE) and clonazepam (CLONOPINE) for unknown indications from unknown start dates and unknown if ongoing. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the right arm on 09Mar2021 at 16:00 (at the age of 56-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 01Apr2021 at 22:00 the patient experienced persistent blurred vision, from 12 days, appeared on 2nd day after vaccine and weakness in the chest area (how one feels after a long flu with severe cough). The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events persistent blurred vision and weakness in the chest area was not recovered at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds: WELLBUTRIN; CLONOPIN

Current Illness:

ID: 1649268
Sex: F
Age:
State: MA

Vax Date: 04/07/2021
Onset Date: 04/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Date: 202010; Test Name: Strep test; Result Unstructured Data: Test Result:tested negative for strep.; Test Date: 202010; Test Name: Herpes virus test; Result Unstructured Data: Test Result:tested negative for herpes.

Allergies:

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Clusters of tiny canker-like sores called enanthem.; develop a rash on the mucus membranes in the back of my mouth and soft palate.; This is a spontaneous report from a contactable consumer, the patient. A 37-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER 8734) via an unspecified route of administration in the right arm on 07Apr2021 at 12:00 (at the age of 37-years-old) as a single dose for COVID-19 immunisation. Medical history included oral rash and suspected COVID-19 in Mar2020. The patient had no known allergies to medications, food, or other products. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021 at 16:00, the patient experienced a rash on the mucus membranes in the back of mouth and soft palate. In the days that followed it had become worse and was now clusters of tiny canker-like sores called enanthem. The patient had this rash a few times since she had a strange cold in March 2020, which the patient now thought may have been COVID. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the event. On an unknown date in Oct2020, the patient underwent lab test which included all strep and herpes tests and the results were negative. The clinical outcome of the event a rash on the mucus membranes in the back of mouth and soft palate, clusters of tiny canker-like sores called enanthem was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1649269
Sex: F
Age:
State: CT

Vax Date: 04/08/2021
Onset Date: 04/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Headache; the next morning followedby dizziness; sweating; 3 days afterhives on my legs, arms and face.; This is a spontaneous report from a contactable consumer, the patient. A 36-year-old non-pregnant female patient received an unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0150), via an unspecified route of administration in the left arm on 08Apr2021 at 15:45(at the age of 36-year-old), as a single dose for COVID-19 immunisation. Medical history was reported as none. The patient did not receive any medication within two weeks of vaccination. The patient had no allergies to food, medication and other products. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 11Apr2021 at 07:30, the patient experienced headache the next morning followed by dizziness and sweating and felt like had a fever, but did not; three days after experienced hives on legs, arms and face. The adverse events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the event headache, dizziness, sweating and hives was resolving at this time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1649270
Sex: M
Age:
State: NC

Vax Date: 04/06/2021
Onset Date: 04/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Bicep and ear rashes have small blisters; Persistently itchy rash on left inner bicep, top of right ear.; Matchbook-sized patch on right waistline; This is a spontaneous report from a contactable consumer, the patient. A 50-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the left arm on 06Apr2021 at 11:00 (at the age of 50-years-old) as a single dose for COVID-19 immunisation. Medical history included rosacea on face (treated successfully with daily metronidazole) and chickenpox. The patient had no allergies to medications, food, or other products. Concomitant medication included metronidazole (MANUFACTURER UNKNOWN) 0.75 (unspecified unit) topical daily for rosacea from an unknown start date. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 08Apr2021 at 08:00, the patient experienced bicep and ear rashes had small blisters, persistently itchy rash on left inner bicep, top of right ear and matchbook-sized patch on right waistline. It was reported that began 48 hrs after vaccination, started as small defined points, then growing and appearance similar to shingles. The patient had not been vaccinated for shingles. She had chicken pox as a child. It was reported that the events did not result in doctor/other health care professional office/clinic visit and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of bicep and ear rashes had small blisters, persistently itchy rash on left inner bicep, top of right ear and matchbook-sized patch on right waistline was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: METRONIDAZOLE

Current Illness:

ID: 1649271
Sex: F
Age:
State: CO

Vax Date: 04/09/2021
Onset Date: 04/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Date: 20210409; Test Name: Body temperature; Result Unstructured Data: Test Result:99.9 (unspecified units); Comments: fever 99.9

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: chills; fever 99.9; Symptoms began 8 hours after the shot including: intense fatigue, headache, body ache, and mild injection site pain. At 24 hours after injection, only fatigue; Symptoms began 8 hours after the shot including: chills, fever 99.9, intense fatigue, headache, body ache, and mild injection site pain. At 24 hours after injection, only fatigue and headache; Symptoms began 8 hours after the shot including: chills, fever 99.9, intense fatigue, headache, body ache, and mild injection site pain; mild injection site pain; This is a spontaneous report from a contactable consumer, the patient. A non-pregnant female patient of 47-year-old received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8732) via an unspecified route of administration in the right arm on 09Apr2021 at 09:15 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. No relevant medical history, she reported that she was healthy at the time of reporting. The patient did not receive any medication within two weeks of vaccination. The patient does not have any allergies to medications, food, or other products. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6204) via an unspecified route of administration in the arm right on 19Mar2021 at 09:15 (at the age of 47-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 09Apr2021 at 17:15, the patient had symptoms began 8 hours after the shot including chills, fever 99.9, intense fatigue, headache, body ache, and mild injection site pain. At 24 hours after injection, only fatigue and headache. At 34 hours after, the patient was feeling well again. On 09Apr2021, the patient checked Body temperature and the result was 99.9(unspecified units). No therapeutic measures were taken as a result of the adverse events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events chills, fever 99.9, body ache, and mild injection site pain were recovered on 10Apr2021. The clinical outcome of the events fatigue and headache were recovered on 10Apr2021 at 21:15. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1649272
Sex: F
Age:
State: TN

Vax Date: 04/09/2021
Onset Date: 04/10/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: Severe rash; This is a spontaneous report from a contactable consumer, the patient. A 22-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Er8731), via an unspecified route of administration in the left arm on 09Apr2021 at 14:00 (at the age of 22-years-old), as a single dose for COVID-19 immunisation. The patient did not have any relevant medical history. The patient did not receive any other medication within two weeks of vaccination. The patient previously took diclofenac (MANUFACTURER UNKOWN) on unknown date for an unspecified indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 10Apr2021 at 09:00, the patient experienced severe rash. Therapeutic measures were not taken as a result of the event. The event did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event severe rash was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am